ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

Amgen: 84% Of Micromet Shares Have Been Tendered

DOW JONES NEWSWIRES Amgen Inc. (AMGN) said nearly 84% of the shares of biotechnology company Micromet Inc. (MITI) have been tendered to its $1.16 billion takeover offer, meeting all the conditions for the acquisition to close. As of the offering's expiration Thursday, about 80 million Micromet shares had been tendered and not withdrawn. An added 3.15 million shares have been tendered by guaranteed delivery. A subsequent offering period is scheduled to expire at 12:00 a.m. EST, at the end of March 6. Amgen launched its bid to acquire Micromet in January with an aim to strengthen Amgen's cancer-drug research pipeline. A Delaware judge declined to block Amgen's purchase of Micromet, the Associated Press reported Thursday. A group of Micromet shareholders had argued that Micromet didn't try hard enough to get a better offer, and sought a preliminary injunction. The judge found that the shareholders didn't show a reasonable likelihood that they would successfully prove their claims, the AP reported. Amgen shares closed at $67.59 Thursday and were inactive premarket. The stock is up 32% in the past 12 months. -By Nathalie Tadena, Dow Jones Newswires; 212-416-3287; nathalie.tadena@dowjones.com

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
05/22/201507:31:00Amgen Receives Positive CHMP Opinion For Use Of Repatha⢠(Evolocumab) F...
05/20/201512:15:10What Is the S&P 500 Index?
05/19/201511:36:02Forget MannKind Stock's Price: Here's What You Need to Focus...
05/18/201516:00:00Amgen Appoints Jonathan P. Graham Senior Vice President, General...
05/17/201509:05:022 Stocks With Jaw-Dropping Growth Potential
05/15/201506:06:00Current Report Filing (8-k)
05/15/201504:00:00Amgen Presents First Phase 2 Data For AMG 334 In The Prevention...
05/14/201517:58:00Amgen Announces Voting Results of Annual Meeting of Stockholders
05/13/201517:00:00Amgen Data At ASCO 2015 Highlight Oncology Pipeline And Portfolio
05/13/201507:17:02The "Best of Breed" Dividend Stocks
05/12/201516:06:00Amgen's Breakaway From Cancer® Announces Winners Of Its Nationwide...
05/12/201510:26:025 Largest Markets for Pharmaceuticals
05/11/201516:58:04Statement of Changes in Beneficial Ownership (4)
05/11/201516:05:00Amgen To Present AMG 334 Data At 17th Congress of the International...
05/11/201511:40:11Court Blocks Novartis Copy of Amgen Cancer-Care Drug
05/08/201517:01:13Regeneron Earnings Shine, but All Eyes Are on the Pipeline
05/07/201513:40:20Court Blocks Novartis Copy of Amgen Cancer-Care Drug
05/07/201513:34:24Court Blocks Novartis Copy of Amgen Cancer-Care Drug
05/04/201516:17:00Amgen To Present At The Deutsche Bank 40th Annual Healthcare...
05/04/201508:05:02Biotech's Blue Chip Stocks

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad